Xeris Biopharma Holdings, Inc. (XERS) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NasdaqGS. Market cap 1.98B USD. 52-week range 5.25 to 11.42 USD. Data as of 2026-10-23.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the ...